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Summary
The syndrome of hypoparathyroidism associated with
growth retardation, developmental delay, and dys-
morphism (HRD) is a newly described, autosomal re-
cessive, congenital disorder with severe, often fatal con-
sequences. Since the syndrome is very rare, with all
parents of affected individuals being consanguineous, it
is presumed to be caused by homozygous inheritance of
a single recessive mutation from a common ancestor. To
localize the HRD gene, we performed a genomewide
screen using DNA pooling and homozygosity mapping
for apparently unlinked kindreds. Analysis of a panel of
359 highly polymorphic markers revealed linkage to
D1S235. The maximum LOD score obtained was 4.11
at a recombination fraction of 0. Analysis of three
additional markers—GGAA6F06, D1S2678, and
D1S179—in a 2-cM interval around D1S235 resulted in
LOD scores 13. Analysis of additional chromosome 1
markers revealed evidence of genetic linkage disequilib-
rium and place the HRD locus within an ∼1-cM interval
defined by D1S1540 and D1S2678 on chromosome
1q42-43.
Introduction
Hypoparathyroidism represents a range of clinical and
biochemical syndromes characterized by parathyroid
hormone (PTH) deficiency, hypocalcemia, and hyper-
phosphatemia. Although transient neonatal hypopara-
thyroidism is relatively common, congenital permanent
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hypoparathyroidism is rare. This latter condition may
be isolated or associated with various syndromes and
chromosome aberrations (Alon and Chan 1985). In ad-
dition to sporadic cases, X-linked recessive (Whyte and
Weldon 1981) and autosomal dominant (Winter et al.
1983) forms have been reported, and the genes causing
these forms have been mapped to Xq26-27 (Thakker et
al. 1990) and 3q13 (Finegold et al. 1994), respectively.
The later gene encodes the calcium-ion–sensing receptor
that responds to, or “senses,” extracellular calcium-ion
concentrations in the parathyroid glands, kidney, and
other tissues (Brown et al. 1995). Mutations in the cal-
cium-sensing receptor were recently shown to be the
cause of autosomal dominant hypoparathyroidism
(Pearce et al. 1996) and of familial benign hypercalcemia
(Pollak et al. 1993; Aida et al. 1995; Chou et al. 1995;
Janicic et al. 1995; Pearce et al. 1995; Health et al.
1996). A donor splice-site mutation in the PTH gene,
located on the short arm of chromosome 11, was as-
sociated with autosomal recessive hypoparathyroidism
in one family (Parkinson and Thakker 1992). Hypo-
parathyroidism may be inherited as part of an autoim-
mune polyendocrinopathy–candidiasis–ectodermal dys-
trophy (APECED) or as part of the DiGeorge syndrome,
in which developmental defects of the third and fourth
pharyngeal pouches result in parathyroid and thymic
aplasia with cardiac and facial anomalies. Genetic stud-
ies have mapped the DiGeorge syndrome to chromo-
some 22q11 (Carey et al. 1992; Driscoll et al. 1992),
and the cause of APECED has been found to be mu-
tations in the zinc-finger domains of a novel gene that
may be a transcription regulator (Finnish-German APE-
CED Consortium 1997; Nagamine et al. 1997). Hy-
poparathyroidism has also been reported in association
with some rare syndromes, such as Zellweger syndrome
(Alon and Chan 1985), Kenny-Caffey syndrome (Fan-
coni et al. 1986), and renal failure due to dysplastic
kidneys, as well as with sensorineural deafness (Shaw et
al. 1991; Bilous et al. 1992) with or without develop-
mental delay. Thus, several genes in different locations
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are probably involved in both normal embryonic de-
velopment of the parathyroid glands and maintenance
of serum calcium homeostasis.
Two reports have been published concerning a new
syndrome of hypoparathyroidism in patients of Arab
origin (Sanjad et al. 1991; Hershkovitz et al. 1995). The
syndrome consists of hypoparathyroidism, severe
growth and mental retardation, and dysmorphic fea-
tures (HRD), including microcephaly, deep-set eyes, flat
nasal bridge, microphthalmia, small hands and feet, and
abnormal dentition. No immunological abnormalities
were observed. Normal karyotypes were found, and
FISH analysis in several patients failed to disclose de-
letion at the DiGeorge locus in 22q11 (Hershkovitz et
al. 1995). These findings in Saudi Arabian and Israeli
Bedouin patients represent a unique syndrome of hy-
poparathyroidism that is clinically and genetically dif-
ferent from the well-known forms of hypoparathyroid-
ism. The inheritance of this syndrome is compatible with
the autosomal recessive model (MIM 241410). Syn-
dromes that are similar but that include a reduced num-
ber of T lymphocytes (Richardson and Kirk 1990) and
medullary stenosis of long bones (Khan et al. 1997) have
also been described in Middle Eastern Arab patients.
Since HRD is a rare disorder, so far found only in
Arab populations, it had been assumed that the disease
is the result of homozygous inheritance of a recessive
mutation from a common ancestor. In this study we
undertook the localization of the HRD gene, using a
DNA-pooling and homozygosity-mapping approach, in
the previously reported Bedouin families (Hershkovitz
et al. 1995), as well as in several newly ascertained fam-
ilies. Homozygosity mapping is based on the realization
that patients with recessive diseases resulting from con-
sanguineous marriages should have increased homozy-
gosity, compared with random expectation, for markers
adjacent to the disease gene (Smith 1953; Lander and
Botstein 1987). Here we report the mapping of the HRD
syndrome to a l-cM interval on 1q42-43 by means of
homozygosity and linkage disequilibrium.
Subjects and Methods
Study Pedigrees
During the past 6 years, we have encountered 12 pa-
tients (6 females and 6 males; fig. 1) from six families
with HRD (Hershkovitz et al. 1995). All were of Bed-
ouin origin, and at least six were from the same clan.
One extended family (pedigree C) had six affected, of
whom two died before the initiation of the study. An-
other family (pedigree E) had two affected individuals,
and four families had one affected each. Initially, eight
patients were available, and DNA pooling was per-
formed. During the course of the study, two new patients
were born into pedigrees D and E. Although the various
nuclear families denied any known genetic relationship
between them, the rarity of the disease and the common
ethnicity suggested a common ancestry.
All patients were affected with intrauterine and severe
postnatal growth retardation (weight, height, and head
circumference 14 SD below the means for age and sex).
After being diagnosed, all patients were treated with a
1-a vitamin D3/calcium supplement. Five patients have
died. Pneumonia and sepsis were the cause of death in
two children; the other three children died at home. Post-
mortem examinations were denied by the families; thus,
the existence and state of the parathyroid glands in the
patients could not be verified. All patients had the typical
dysmorphic features described elsewhere (Hershkovitz
et al. 1995) but no cardiac or other major malformation.
Severe psychomotor delay was evident in early infancy.
Undetectable or very low serum PTH levels in the pres-
ence of severe persistent hypocalcemia and hyperphos-
phatemia confirmed the diagnosis of permanent hypo-
parathyroidism. There was an absence of immunological
and chromosomal abnormalities, and no medullary ste-
nosis of long bones was found. Although the patients’
phenotype resembles that of Kenny-Caffey syndrome,
recently described in Bedouins from Kuwait (Khan et al.
1997), the absence of cortical thickening or overtubu-
lation of long bones suggested that our patients have the
unique syndrome of HRD first described, in Saudi Ara-
bian patients, by Sanjad et al. (1991). Inheritance of the
syndrome in the families reported here is compatible
with the autosomal recessive mode.
Homozygosity Mapping and DNA Pooling
The study was approved by the Soroka Medical Cen-
ter review board. DNA was prepared, by use of standard
methods, from 10–20-ml samples of peripheral blood.
Fifty nanograms of DNA from each individual was used
in the pools. The genomewide screening was performed
for two sets of pooled samples, as detailed in the Results
section.
Microsatellite Markers and Genotyping
The short tandem-repeat polymorphic markers
(STRPs) used were developed by the Cooperative Hu-
man Linkage Center (CHLC; Sheffield 1997) and pur-
chased from Research Genetics. These markers are ar-
ranged in 150 groups of two to three markers that PCR
amplifies together. PCR, gel separation, and silver-stain-
ing conditions were performed in accordance withmeth-
ods described by Sheffield (1997). Regions with non-
informative markers were filled with dinucleotide mar-
kers from the Weber version 8 genome screening set
(Research Genetics). PCR conditions were as described
above, except that 0.01 mCi of a-[32P] dCTP was in-
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Figure 1 HDR pedigrees showing the recessive inheritance of the disease. The genotypes are presented under each individual analyzed
in this study. The haplotypes showing homozygous inheritance near the HDR locus in each pedigree are boxed. The genetic distances between
the markers are shown. Their distances and order are based on information derived from the recombination maps compiled by the Third
International Workshop on Human Chromosome 1 (Chromosome 1 homepage).
cluded in the reaction, and PCR products were visualized
by exposure of the gels to Kodak X-ray film overnight.
Linkage Analysis
Two-point LOD scores (Z) were computed by the
LINKAGE and FASTLINK programs (Lathrop et al.
1984; Cottingham et al. 1993). A penetrance of 100%
was assumed. Equal allele frequencies were assumed for
each marker.
Results
A total of 353 STRPs distributed at ∼10-cM intervals
through all autosomes (Sheffield 1997) were first
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v.00 .01 .05 .10 .20 .30 .40
D1S3642 ATA29C07 6.2  .083 .01 .25 .26 .13 .02 .29 .15
D1S446 AFM238ya7 4.3 1.87 1.81 1.54 1.23 .66 .27 .06 1.87 .00
D1S2800 AFMb360zg1 4.2  2.89 3.03 2.65 1.69 .86 .30 3.09 .03
D1S179 mfd174 2.0 3.74 3.65 3.24 2.70 1.67 .84 .30 3.74 .00
D1S2712 AFMa349xc5 1.6  1.26 1.71 1.67 1.25 .73 .30 1.73 .07
D1S1540 UT1317 1.0 2.00 2.20 2.27 2.03 1.37 .77 .33 2.30 .03
D1S235 AFM203yg9 0 4.11 3.98 3.49 2.89 1.82 .98 .40 4.11 .00
GGAA6F06 0 3.49 3.41 3.06 2.63 1.80 1.05 .45 3.49 .00
D1S2678 AFMa245wd5 0 3.18 3.35 3.30 2.92 1.98 1.11 .45 3.40 .02
D1S2680 AFMa247yg9 0 2.49 2.74 2.77 2.44 1.61 .88 .36 2.83 .03
AFM214xe1 0 .94 .13 .79 .94 .80 .49 .20 .94 .11
D1S2850 AFM088xe5 7.2 1.54 2.30 2.56 2.38 1.73 1.02 .43 2.57 .04
D1S373 UT492 8.2 1.15 .67 .10 .41 .50 .36 .16 .51 .17
D1S2670 AFMa230wh1 9.4 .30 .71 1.31 1.47 1.27 .85 .40 1.48 .11
D1S517 UT1570 9.5 .65 .92 1.31 1.37 1.11 .72 .34 1.38 .09
D1S1149 UT418 11.4 2.55 2.48 2.21 1.88 1.28 .75 .33 2.55 .00
a Distances from D1S235.
screened in two sets of pools. The first set was from the
extended family (pedigree C; fig. 1) and included a pool
of four patients and a pool of their four parents. The
second set consisted of four nuclear families, each with
one patient (pedigrees A, B, and D and patient 50 of
pedigree E; fig. 1), and included a patient pool (four
patients), a parent pool (seven parents), and a sibling
pool (seven siblings). This strategy was used both to
avoid type I error in case of genetic heterogeneity and
to establish linkage in at least the largest family studied
in which genetic homogeneity could be assumed. This
first screening failed to find any clear linkage. Since some
of the STRPs were not informative, the gaps of 15–10
cM were closed by use of markers from the CHLC/
Weber 8th version genome-screening set. The addition
of six more microsatellite markers revealed one intense
band corresponding to allele 2 of D1S235 in the two
patient pools, whereas the parent pool and the sibling
pool showed several bands. Individual genotyping of
each patient and of unaffected family members (includ-
ing the newborn patients and their families) revealed that
all 10 patients were homozygous for allele 2. The pair-
wise Z value for the HRD locus, with D1S235, is 4.11
at a recombination fraction (v) of 0 (table 1).
To further refine the localization of the HRD interval,
we analyzed all patients and relatives of families C and
E for microsatellite markers flanking D1S235 (fig. 1).
The markers cover a 21-cM interval on chromosome
1q41-44. D1S179 and D1S2678 define the centromeric
and telomeric boundaries for HDR, respectively, show-
ing heterozygous alleles in intrafamilial haplotypes (ped-
igree E, patient 50; fig. 1). These flanking loci are 4.2
cM apart (information derived from the recombination
maps compiled by the Third International Workshop on
Human Chromosome 1 and available at the Chromo-
some 1 homepage). The Z values obtained for the two
large families (C and E) were 2.54 for D1S235 and 3.49
and 3.05 for the tightly linked GGAA6F06 and
D1S2678, respectively. No individuals without hypo-
parathyroidism had the patients’ homozygous pheno-
type, as can be seen in figure 1.
The interval containing the HRD gene could be further
narrowed by means of a search for a shared haplotype
in all affected individuals. The analysis of all 10 patients
for haplotypes at the loci flanking D1S235 (fig. 2) is
presented in figure 3. Since D1S235 and the nearby
marker GGAA6F06 are homozygous for the same alleles
in all HRD patients, we assumed that these alleles were
in linkage disequilibrium with the HRD gene. Patients
50 and 43 showed heterozygosity at D1S2678, thus de-
fining the telomeric border. Patients 7, 50, 53, and 43
show, at locus D1S1540, alleles that are different than
those of the remaining patients, thus defining the cen-
tromeric border (fig. 3). The HDR interval is therefore
confined between the flanking markers D1S2678 and
D1S1540, an interval of 1 cM, on the basis of the re-
combination maps compiled by the Third International
Workshop on Human Chromosome 1 (Chromosome 1
homepage).
Discussion
Homozygosity mapping is a powerful technique that
is used to map genes responsible for recessive diseases
and is applied mostly in large consanguineous pedigrees
(Sheffield et al. 1995). Here we present the localization
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Figure 2 Genetic map of chromosome 1q42-43 region, showing
the location of the HDR gene. The genetic distances between themark-
ers, as well as their order, are based on information derived from the
recombination maps compiled by the Third International Workshop
on Human Chromosome 1 (Chromosome 1 homepage).
Figure 3 Multilocus haplotypes for polymorphic markers near
the HDR gene in 10 patients. The patients in the extended families
are grouped, and the family to which they belong is indicated. The
chromosomes showing homozygous alleles in patients are boxed.
of the rare HRD gene, using this method in apparently
unrelated families that belong to a relatively small Bed-
ouin population, and thus demonstrate the use of this
technique when a common ancestor is assumed. Evi-
dence of linkage to this interval was provided by both
significant Z values and homozygosity of markers across
the disease interval. The fact that the families are not
closely related necessitated screening of markers at in-
tervals of 5 cM. The data on nuclear families aided in
the narrowing of the HRD gene interval, thus revealing
that all patients share the same alleles at only two tightly
linked marker loci, D1S235 and GGAA6F06, with the
flanking markers D1S2678 and D1S1540 defining a dis-
tance of 1 cM for the gene interval. It is highly plausible
that both the mutation that we found and that of the
Saudi Arabian patients represent one single HRD mu-
tation that occurred generations ago in the Bedouin pop-
ulation migrating into the region of Israel and the Arab
peninsula. Recently, the strength of using homozygosity
and linkage disequilibrium even when large consan-
guineous families are not available was demonstrated by
the mapping of the urofacial (Ochoa) syndrome to a 1-
cM interval on chromosome 10 (Wang et al. 1997) and
of the cerebellar ataxia locus to a small physical interval
on chromosome 19p13.3 (Nystuen et al. 1996), in mem-
bers of nuclear families from a large Columbian popu-
lation and in an isolated population from the Cayman
Islands, respectively. In all of these cases, the many mei-
oses that occurred since the mutation appeared and
spread from the common ancestor to the apparently un-
related families enabled a significant narrowing of the
interval of search for the affected genes. The small in-
terval of search for the HRD gene makes the task of its
positional cloning feasible.
The gene for Chediak-Higashi syndromewas localized
exactly at D1S235, flanked by markers D1S236 and
D1S2680 (Barrat et al. 1996). However, this disorder
bears no resemblance to HRD. Several additional genes
were localized within the interval, including Rab escort
protein-2 and inositol 1,4,5-triphosphate 3-kinase (Bar-
rat et al. 1997), none of which appears a priori to be
an obvious candidate for HRD. A syntenic mouse region
exists on chromosome 13 (U.K. Human Genome Map-
ping Project). This region of the mouse genome does not
contain any obvious candidate gene or a similar phe-
notype in the mouse (U.K. Human Genome Mapping
Project). Forty-eight cDNAs (National Center for Bio-
technology Information Human GeneMap) were placed
in the 16-cM interval D1S446–D1S304, around
D1S235. Fine mapping of these expressed sequence tags
(ESTs) and examination of the expression pattern is a
logical next step in defining which, if any, of these ESTs
is responsible for HRD. A YAC contig of this region
already exists (Barrat et al. 1996).
Identification of the gene that, when mutated, causes
HRD may contribute to the understanding of the pro-
cesses involved in the regulation of production and se-
cretion of PTH. Since serum-ionized calcium closely reg-
ulates the production of the hormone, insight may be
gained into the regulation of ionized calcium homeosta-
sis as well. Indeed, in six kindreds diagnosed with au-
tosomal dominant hypoparathyroidism, gain-of-func-
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tion mutations were recently found in the cal-
cium-sensing receptor (Pearce et al. 1996). The growth
and mental retardation observed in HRD patients was
not reported in the various forms of isolated hypopar-
athyroidism. Apparently this is not caused by the hy-
poparathyroidism that per se still allows normal growth
(Gorodischer et al. 1970), and it may represent a unique
pleiotropic effect of the gene on fetal development and
postnatal growth. The very similar Kenny-Caffey syn-
drome observed in Bedouins (Khan et al. 1997) might
be caused by a different mutation in the HRD gene or
might represent genetic heterogeneity for a similar
phenotype.
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